Suchergebnisse - "Della-Torre, Emanuel"

PubPharm (145)

1

Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center

enthalten in: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al. | 2024

von Lanzillotta, M. | Belli, L. | Belfiori, G. | +8

2

Type 1 Autoimmune Pancreatitis in Europe : Clinical Profile and Response to Treatment

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2024

von Overbeek, K. | Poulsen, J. | Lanzillotta, M. | +80

3

Fibrotic phenotype of IgG4-related disease

enthalten in: The Lancet. Rheumatology | 2024

von Lanzillotta, M. | Culver, E. | Sharma, A. | +4

4

Efficacy of Siltuximab and 1,927 nm Fractional Laser for the Treatment of Cutaneous Manifestations in Castleman's Disease : The Role of Dermoscopy and Reflectance Confocal Microscopy for Lesion Evaluation

enthalten in: Case reports in dermatology | 2024

von Paolino, G. | Ardigò, M. | Della-Torre, E. | +7

5

Lymphadenopathy in the rheumatology practice : a pragmatic approach

enthalten in: Rheumatology (Oxford, England) | 2023

von Rodolfi, S. | Della-Torre, E. | Bongiovanni, L. | +3

6

Interleukin-6 inhibition for the treatment of IgG4 related vasculitis

enthalten in: European journal of internal medicine | 2023

von Batani, V. | Minici, C. | Sanvito, F. | +3

7

Efficacy and Safety of Inebilizumab in IgG4-Related Disease : Protocol for a Randomized Controlled Trial

enthalten in: Rheumatology and therapy | 2023

von Perugino, C. | Culver, E. | Khosroshahi, A. | +10

8

Ustekinumab as Induction and Maintenance Therapy in Patients with Inflammatory Bowel Disease and Type II Autoimmune Pancreatitis : Report of Two Cases

enthalten in: Journal of Crohn's & colitis | 2023

von Lauri, G. | D'Amico, F. | Allocca, M. | +7

ErratumIn: J Crohns Colitis. 2024 Jan 19;:. - PMID 38243803

9

B-cell depletion with obinutuzumab for the treatment of IgG4-related disease

enthalten in: European journal of internal medicine | 2023

von Lanzillotta, M. | Mapelli, P. | Dagna, L. | +1

CommentOn: Rheumatology (Oxford). 2022 Aug 30;61(9):3814-3817. - PMID 34958343

10

Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial

enthalten in: Rheumatology and therapy | 2023

von Perugino, C. | Culver, E. | Khosroshahi, A. | +10

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]